The will provide up to $28 million for medical research and innovation projects that:
- support the development of novel diagnostic or monitoring tools, or therapies for people living with PASC
- improve the quality of care for people who have symptoms or are living with PASC.
PASC is also known as long COVID.
This is the second grant opportunity under the $50 million . Funding is from the MRFF’s .
/Media Release. View in full .